Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

30.75 +1.50 (+5.11%)
Streaming Delayed Price Updated: 12:26 PM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,187,774
Open 29.43
Bid (Size) 30.72 (2)
Ask (Size) 30.77 (1)
Prev. Close 29.25
Today's Range 29.13 - 31.00
52wk Range 8.241 - 32.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga

Performance

YTD
+151.0%
+151.0%
1 Month
+136.0%
+136.0%
3 Month
+98.1%
+98.1%
6 Month
+207.1%
+207.1%
1 Year
+157.3%
+157.3%

More News

Read More
Here are the top movers in Tuesday's session.
Via Chartmill
Earnings Preview For Mineralys Therapeutics
Via Benzinga
Earnings Scheduled For May 12, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.
Via Chartmill
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Nasdaq Down 1%; Signet Jewelers Earnings Top Views
Via Benzinga
Tuesday's pre-market session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results
Via Investor's Business Daily
Nasdaq 100, S&P 500 Hit New All-Time Highs, Airlines Jump: What's Moving Markets Tuesday?
Via Benzinga
Topics Economy Stocks
Earnings Scheduled For August 12, 2025
Via Benzinga
Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps
Via Benzinga
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Uncovering Potential: Mineralys Therapeutics's Earnings Preview
Via Benzinga
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1
Via Stocktwits
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
Via Stocktwits
Unusual volume stocks are being observed in Wednesday's session.
Via Chartmill
Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Keep an eye on the top gainers and losers in Monday's session.
Via Chartmill
Monday's session: top gainers and losers
Via Chartmill

Frequently Asked Questions

Is Mineralys Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mineralys Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mineralys Therapeutics, Inc. - Common Stock trade on?
Mineralys Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mineralys Therapeutics, Inc. - Common Stock?
The ticker symbol for Mineralys Therapeutics, Inc. - Common Stock is MLYS on the Nasdaq Stock Market
What is the current price of Mineralys Therapeutics, Inc. - Common Stock?
The current price of Mineralys Therapeutics, Inc. - Common Stock is 30.75
When was Mineralys Therapeutics, Inc. - Common Stock last traded?
The last trade of Mineralys Therapeutics, Inc. - Common Stock was at 09/04/25 12:26 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.